These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34911431)

  • 1. Commentary on the Article "Multiple Hormonal and Metabolic Deficiency Syndrome Predicts Outcome in Heart Failure: The T.O.S.CA. Registry", Antonio Cittadini
    Triggiani V; Lisco G
    Endocr Metab Immune Disord Drug Targets; 2022; 22(6):545-548. PubMed ID: 34911431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry.
    Cittadini A; Salzano A; Iacoviello M; Triggiani V; Rengo G; Cacciatore F; Maiello C; Limongelli G; Masarone D; Perticone F; Cimellaro A; Perrone Filardi P; Paolillo S; Mancini A; Volterrani M; Vriz O; Castello R; Passantino A; Campo M; Modesti PA; De Giorgi A; Monte IP; Puzzo A; Ballotta A; D'Assante R; Arcopinto M; Gargiulo P; Sciacqua A; Bruzzese D; Colao A; Napoli R; Suzuki T; Eagle KA; Ventura HO; Marra AM; Bossone E;
    Eur J Prev Cardiol; 2021 Dec; 28(15):1691-1700. PubMed ID: 33693736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry.
    Bossone E; Arcopinto M; Iacoviello M; Triggiani V; Cacciatore F; Maiello C; Limongelli G; Masarone D; Perticone F; Sciacqua A; Perrone-Filardi P; Mancini A; Volterrani M; Vriz O; Castello R; Passantino A; Campo M; Modesti PA; De Giorgi A; Monte I; Puzzo A; Ballotta A; Caliendo L; D'Assante R; Marra AM; Salzano A; Suzuki T; Cittadini A;
    Intern Emerg Med; 2018 Aug; 13(5):661-671. PubMed ID: 29619769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-1 (IGF-1) as predictor of cardiovascular mortality in heart failure patients: data from the T.O.S.CA. registry.
    De Giorgi A; Marra AM; Iacoviello M; Triggiani V; Rengo G; Cacciatore F; Maiello C; Limongelli G; Masarone D; Perticone F; Filardi PP; Paolillo S; Mancini A; Volterrani M; Vriz O; Castello R; Passantino A; Campo M; Modesti PA; Salzano A; D'Assante R; Arcopinto M; Raparelli V; Fabbian F; Sciacqua A; Colao A; Suzuki T; Bossone E; Cittadini A;
    Intern Emerg Med; 2022 Sep; 17(6):1651-1660. PubMed ID: 35445917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-1 predicts survival in chronic heart failure. Insights from the T.O.S.CA. (Trattamento Ormonale Nello Scompenso CArdiaco) registry.
    Arcopinto M; Isgaard J; Marra AM; Formisano P; Bossone E; Vriz O; Vigorito C; Saccà L; Douglas PS; Cittadini A
    Int J Cardiol; 2014 Oct; 176(3):1006-8. PubMed ID: 25037691
    [No Abstract]   [Full Text] [Related]  

  • 6. Anabolic Deficiencies in Heart Failure: Ready for Prime Time?
    Napoli R; D'Assante R; Miniero M; Salzano A; Cittadini A
    Heart Fail Clin; 2020 Jan; 16(1):11-21. PubMed ID: 31735309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple hormone deficiencies in chronic heart failure.
    Arcopinto M; Salzano A; Bossone E; Ferrara F; Bobbio E; Sirico D; Vriz O; De Vincentiis C; Matarazzo M; Saldamarco L; Saccà F; Napoli R; Iacoviello M; Triggiani V; Isidori AM; Vigorito C; Isgaard J; Cittadini A
    Int J Cardiol; 2015 Apr; 184():421-423. PubMed ID: 25755056
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormonal alterations in heart failure: anabolic impairment in chronic heart failure - diagnostic, prognostic and therapeutic issues.
    Arcopinto M; Cittadini A
    Front Horm Res; 2014; 43():57-69. PubMed ID: 24943298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anabolic Hormones Deficiencies in Heart Failure With Preserved Ejection Fraction: Prevalence and Impact on Antioxidants Levels and Myocardial Dysfunction.
    Bruno C; Silvestrini A; Calarco R; Favuzzi AMR; Vergani E; Nicolazzi MA; d'Abate C; Meucci E; Mordente A; Landolfi R; Mancini A
    Front Endocrinol (Lausanne); 2020; 11():281. PubMed ID: 32477267
    [No Abstract]   [Full Text] [Related]  

  • 10. Anabolic Deficiencies in Heart Failure: Ready for Prime Time?
    Napoli R; D'Assante R; Miniero M; Salzano A; Cittadini A
    Cardiol Clin; 2022 May; 40(2):149-159. PubMed ID: 35465889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anabolic/catabolic imbalance in chronic heart failure].
    Cittadini A; Bossone E; Marra AM; Arcopinto M; Bobbio E; Longobardi S; Cevara C; Di Michele S; Saccà L
    Monaldi Arch Chest Dis; 2010 Jun; 74(2):53-6. PubMed ID: 21280284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal deficiencies in heart failure with preserved ejection fraction: prevalence and impact on diastolic dysfunction: a pilot study.
    Favuzzi AMR; Venuti A; Bruno C; Nicolazzi MA; Fuorlo M; Dajko M; De Waure C; Landolfi R; Mancini A
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):352-361. PubMed ID: 31957849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Tosca Registry: An Ongoing, Observational, Multicenter Registry for Chronic Heart Failure.
    Arcopinto M; Salzano A; Ferrara F; Bobbio E; Marra AM; Abete R; Stagnaro F; Polizzi R; Giallauria F; Illario M; Menditto E; Vigorito C; Bossone E; Cittadini A
    Transl Med UniSa; 2016 May; 14():21-7. PubMed ID: 27326392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study.
    Bahrami H; Bluemke DA; Kronmal R; Bertoni AG; Lloyd-Jones DM; Shahar E; Szklo M; Lima JA
    J Am Coll Cardiol; 2008 May; 51(18):1775-83. PubMed ID: 18452784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Growth hormone secretion in heart failure].
    Giustina A; Bonadonna S; Burattin A; Manelli F; Lorusso R; Volterrani M; Villa S; Dei Cas L; Agabiti Rosei E
    Minerva Endocrinol; 2003 Mar; 28(1):1-11. PubMed ID: 12621359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival.
    Jankowska EA; Biel B; Majda J; Szklarska A; Lopuszanska M; Medras M; Anker SD; Banasiak W; Poole-Wilson PA; Ponikowski P
    Circulation; 2006 Oct; 114(17):1829-37. PubMed ID: 17030678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Hormonal Abnormalities in Heart Failure Patients.
    Gargiulo P; Paolillo S; Ferrazzano F; Prastaro M; La Mura L; De Roberto AM; Diana G; Dell'Aversana S; Contiello C; Vozzella MC; Bardi L; Marsico F
    Heart Fail Clin; 2019 Jul; 15(3):371-375. PubMed ID: 31079695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome.
    Dandona P; Dhindsa S; Chaudhuri A; Bhatia V; Topiwala S; Mohanty P
    Curr Mol Med; 2008 Dec; 8(8):816-28. PubMed ID: 19075678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impairment of the Growth Hormone/Insulin-like growth factor 1 (IGF-1) axis in heart failure: A possible target for future therapy.
    Piccioli L; Arcopinto M; Salzano A; D'Assante R; Schiavo A; Stagnaro FM; Lombardi A; Panicara V; Valente P; Vitale G; Sarullo FM; Giallauria F; Marra AM
    Monaldi Arch Chest Dis; 2018 Sep; 88(3):975. PubMed ID: 30183158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.